Local applied medicine composition for curing subcutaneous tumor

A technology for topical administration and composition, applied in the field of topical administration of pharmaceutical compositions, can solve problems such as the efficacy of arsenic trioxide in treating tumors that is not described

Inactive Publication Date: 2003-04-09
TTY BIOPHARM
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The above-mentioned literature does not describe the efficacy of arsenic trioxide in the treatment of tumors, especially in the treatment of diseases related to subcutaneous tumors

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Local applied medicine composition for curing subcutaneous tumor
  • Local applied medicine composition for curing subcutaneous tumor
  • Local applied medicine composition for curing subcutaneous tumor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0014] In the present invention, arsenic trioxide (chemical formula is As 2 o 3 ), which are white or transparent amorphous blocks or crystals, not easily soluble in water, and have a sweet taste. It is highly toxic and is generally used to make glass, enamel and other substances.

[0015] The pharmaceutical composition of the present invention has excellent curative effect on diseases related to subcutaneous tumors, such as primary skin cancer, melanomatous cancer or metastatic cutaneous cancer and other cancers. Primary skin cancers include basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and Merkel cell carcinoma.

[0016] A "therapeutically effective amount" as referred to herein is an amount sufficient to provide a therapeutic effect when administered to a mammal in need of such treatment. The therapeutically effective amount will depend on various factors such as the individual and the condition to be treated, the weight and age of the individual, the severit...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The locally applied medicine composition for treating subcutaneous tumor includes As2O3 in effective amount and pharmaceutically acceptable carrier. It is used in treating primary skin cancer, melanin cancer or metastatic subcutaneous cancer.

Description

technical field [0001] The present invention relates to a locally administered pharmaceutical composition for treating subcutaneous tumors, especially a locally administered pharmaceutical composition for treating primary skin cancer, melanoma or metastatic subcutaneous cancer. Background technique [0002] Arsenic trioxide can be used as a herbicide and can also be used to kill rodents and insects. It can be used as a parasiticide in general medicine, and it is also an ingredient in traditional Chinese medicine. Its main medical use is to treat anemia and indigestion, and it can also be used as a pulp inactivator for the treatment of pulp diseases; it is also Treat psoriasis, syphilis and rheumatism with the principle of "fighting poison with poison". As early as the 1820s, arsenic trioxide was recognized as a potential co-carcinogen of human malignancies, especially skin and lung cancers. Because of its carcinogenicity, current medical use is limi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K33/36A61P35/00
Inventor 黄明哲胡宇方
Owner TTY BIOPHARM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap